Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07226284 · ClinicalTrials.gov registry record · NA

Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease

A NA study of Parkinsons Disease (PD) and PARKINSON DISEASE (Disorder), sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT07226284 is a NA study of Parkinsons Disease (PD) and PARKINSON DISEASE (Disorder) that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 75 participants, below the 116-participant average among 19 other Parkinsons Disease (PD) trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07226284, a NA study of Parkinsons Disease (PD) and PARKINSON DISEASE (Disorder), is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

This study is designed to better understand the mechanisms contributing to impaired activation of leg muscles in people with Parkinson's disease (PD) and to test if stimulation of a nerve at the neck can improve muscle activation, walking and balance.

Interventions

  • OTHER No intervention
  • DEVICE Vagal nerve stimulation

Study Locations (1)

Minnesota

  • Movement Disorders Laboratory - Minneapolis

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2026-02-10
Est. Completion 2029-01
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT07226284

The ClinicalTrials.gov registry entry for NCT07226284 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 116-participant average among 19 other Parkinsons Disease (PD) trials with a reported enrollment target (35% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Parkinsons Disease (PD) appearing as the primary indexed condition, and to 2 interventions - of which No intervention is the first listed.

NCT07226284 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT07226284 about?

NCT07226284 is a clinical study titled "Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease". This study is designed to better understand the mechanisms contributing to impaired activation of leg muscles in people with Parkinson's disease (PD) and to test if stimulation of a nerve at the neck can improve muscle activation, walking and balance.

What is the current status of trial NCT07226284?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2026-02-10. Estimated completion is 2029-01.

What conditions does trial NCT07226284 study?

This clinical trial studies the following conditions: Parkinsons Disease (PD), PARKINSON DISEASE (Disorder).

What interventions are being tested in trial NCT07226284?

The interventions under investigation include: No intervention (OTHER), Vagal nerve stimulation (DEVICE).

Who is sponsoring clinical trial NCT07226284?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07226284 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinsons Disease (PD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.